Susquehanna Fundamental Investments, LLC Rubius Therapeutics, Inc. Transaction History

Susquehanna Fundamental Investments, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$17.6 - $25.91 $256,080 - $376,990	-14,550 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$22.26 - $28.43 $25,599 - $32,694	-1,150 Reduced 7.32%	14,550 $355,000
Q1 2021 May 17, 2021	SELL	$8.02 - $32.01 $67,712 - $270,260	-8,443 Reduced 34.97%	15,700 $416,000
Q4 2020 Feb 16, 2021	SELL	$4.23 - $8.73 $38,311 - $79,067	-9,057 Reduced 27.28%	24,143 $183,000
Q3 2020 Nov 16, 2020	BUY	$4.65 - $6.25 $54,870 - $73,750	11,800 Added 55.14%	33,200 $166,000
Q2 2020 Aug 14, 2020	BUY	$4.01 - $6.88 $85,814 - $147,232	21,400 New	21,400 $128,000

325

Ticker RUBY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 90,357,000
Description
Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatmen...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.